|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Net product revenues | |||
| License and collaboration revenues | |||
| Total revenue | |||
| Operating expenses | |||
| General and administrative expenses | |||
| Cost of goods sold | |||
| Selling, general and administrative | |||
| Research and development | |||
| Professional fees | |||
| Amortization of intangible assets | |||
| Total operating expenses | |||
| Operating loss | |||
| Interest expense | |||
| Other income | |||
| Gain on default judgement | |||
| Other (expense) income | |||
| Interest expense | |||
| Impairment of intangible assets | |||
| Change in fair value of convertible debt | |||
| Interest income and other income | |||
| Total other (expense) income | |||
| Net loss before provision for income taxes | |||
| Net loss before provision for income taxes | |||
| Provision for income taxes | |||
| Net loss | |||
| Comprehensive loss | |||
| Net loss per common share, basic (in dollars per share) | |||
| Net loss per common share, diluted (in dollars per share) | |||
| Weighted average number of common shares outstanding, basic (in shares) | |||
| Weighted average number of common shares outstanding, diluted (in shares) |
Loading...